What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Typhoid Fever

Azithromycin 500 mg once daily for 7 days is the recommended first-line treatment for typhoid fever, particularly in areas with high fluoroquinolone resistance, due to its superior efficacy, lower risk of clinical failure, and shorter hospital stays. 1

First-Line Treatment Options

  • Azithromycin 500 mg once daily on day 1, followed by 500 mg once daily for 6 more days (total 7 days) is the preferred treatment for adults with typhoid fever 2
  • Azithromycin demonstrates superior efficacy compared to fluoroquinolones for treating typhoid fever, with a lower risk of clinical failure (OR 0.48) and shorter hospital stays 2
  • Azithromycin has a lower risk of relapse (OR 0.09) compared to ceftriaxone and is particularly effective against quinolone-resistant strains 1, 2

Alternative Treatment Options Based on Resistance Patterns

  • For fully susceptible S. typhi strains, fluoroquinolones (ofloxacin or ciprofloxacin) or alternatives such as chloramphenicol, amoxicillin, or trimethoprim-sulfamethoxazole can be considered 1
  • For severe cases, intravenous ceftriaxone may be used initially, with transition to oral therapy when clinically improved 3
  • Ciprofloxacin is FDA-approved for typhoid fever but should not be used empirically for cases originating from South Asia due to high resistance rates 4, 5

Special Considerations

  • For patients with clinical features of sepsis, broad-spectrum antimicrobial therapy should be started after collection of blood, stool, and urine cultures 3
  • Expected fever clearance is within 4-5 days of appropriate therapy 1
  • Treatment should be guided by local resistance patterns, as resistance to fluoroquinolones is common, particularly among travelers to South and Southeast Asia 1, 5
  • The addition of steroids may be helpful in severe cases of typhoid fever 3

Pediatric Dosing

  • For children with typhoid fever, azithromycin at 10 mg/kg/day (maximum 500 mg/day) for 7 days has shown high cure rates (91%) 6
  • Alternatively, ceftriaxone at 75 mg/kg/day (maximum 2.5 g/day) can be used for children 6

Monitoring and Follow-up

  • Monitor for clinical response, with expected fever clearance within 4-5 days of appropriate therapy 1
  • Watch for potential drug interactions with azithromycin, particularly with agents metabolized by cytochrome P450 enzyme system 2
  • Common adverse effects of azithromycin include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 2

Treatment Failure Management

  • If poor response to azithromycin occurs, consider confirming antimicrobial susceptibility testing if available 2
  • Alternative options include switching to a third-generation cephalosporin (e.g., ceftriaxone) or combination therapy with cefixime 2
  • Ceftriaxone has shown efficacy in bacteremic typhoid fever with a mean defervescence period of 4 days 7

Prevention

  • Typhoid vaccination provides incomplete protection and does not protect against paratyphoid 1, 3
  • Careful selection of food and drink is essential, as typhoid vaccines are not 100% effective 8

Pitfalls to Avoid

  • Avoid using ciprofloxacin empirically for cases originating from South Asia due to high resistance rates 1, 5
  • Cefixime may not perform as well as fluoroquinolones for typhoid treatment 9
  • Do not rely solely on vaccination for prevention, as it provides incomplete protection 1, 3

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Azithromycin Treatment for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Fever with Positive Typhoid Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000

Research

Ceftriaxone therapy in bacteremic typhoid fever.

Antimicrobial agents and chemotherapy, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.